| 000 | 01105 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250514214743.0 | ||
| 264 | 0 | _c20050217 | |
| 008 | 200502s 0 0 eng d | ||
| 022 | _a0003-9926 | ||
| 024 | 7 |
_a10.1001/archinte.165.2.158 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSolomon, Daniel H | |
| 245 | 0 | 0 |
_aCoxibs, science, and the public trust. _h[electronic resource] |
| 260 |
_bArchives of internal medicine _cJan 2005 |
||
| 300 |
_a158-60 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Comparative Study; Editorial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdverse Drug Reaction Reporting Systems |
| 650 | 0 | 4 | _aConsumer Product Safety |
| 650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aDrug Industry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPublic Opinion |
| 650 | 0 | 4 |
_aScience _xstandards |
| 650 | 0 | 4 | _aTrust |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aAvorn, Jerry | |
| 773 | 0 |
_tArchives of internal medicine _gvol. 165 _gno. 2 _gp. 158-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/archinte.165.2.158 _zAvailable from publisher's website |
| 999 |
_c15346834 _d15346834 |
||